Connect with us

Hi, what are you looking for?

Editor's Pick

RFK Jr’s HHS to end routine COVID vaccine guidance for children, pregnant women: report

The Trump administration is backing away from the Centers for Disease Control and Prevention (CDC) recommendations to vaccinate children and pregnant women against COVID-19, according to a new report.

The Department of Health and Human Services (HHS), led by Secretary Robert F. Kennedy, Jr., is planning to pull federal recommendations that these groups get the COVID vaccine as a routine measure, The Wall Street Journal reported Thursday.

The CDC currently recommends that everyone aged 6 months and older get vaccinated, but that guidance may be scrapped in the coming days.

It’s unclear whether HHS plans to drop the recommendation entirely or simply stop pushing it for everyone across the board, the report said.

The move would be a major shift in federal health policy and would mark a break from the blanket-vaccine approach that dominated the early years of the pandemic.

Few parents and expectant mothers have followed through with recent COVID boosters. As of April, CDC data shows just 13% of children and 14% of pregnant women had received the latest shot.

The change comes as the FDA, under Commissioner Dr. Marty Makary, prepares to roll out a tougher approval process for vaccines.

Speaking Thursday at a gathering of food and drug lawyers, Makary said, ‘We want to see vaccines that are available for high-risk individuals, and at the same time, we want some good science. We want some good clinical data.’

Kennedy has long been critical of mRNA vaccines and mass vaccination campaigns. As HHS secretary, he now has the authority to revise CDC guidance.

The Trump administration said it plans to drop routine COVID vaccination guidance for kids and pregnant women, marking a major shift in federal health policy, the WSJ reported.

The expected shift would undercut one of the most promoted health policies of the first Trump administration, Operation Warp Speed, and raise questions about whether insurers will continue covering the shots.

Critics of the move told the Journal it could discourage vaccination and leave immunocompromised people more vulnerable. Supporters say it brings policy back in line with science and common sense.

Both HHS and CDC did not immediately respond to Fox News Digital’s request for comment.

This post appeared first on FOX NEWS

    Fill Out & Get More Relevant News


    Stay ahead of the market and unlock exclusive trading insights & timely news. We value your privacy - your information is secure, and you can unsubscribe anytime. Gain an edge with hand-picked trading opportunities, stay informed with market-moving updates, and learn from expert tips & strategies.

    You May Also Like

    Investing

    Newmont (NYSE: NEM) reported mixed financial results even as the price of gold approached its all-time high. In all, the company’s earnings per share...

    Investing

    Fisker (NYSE: FSR) stock price has been one of the best-performing electric vehicle (EV) stocks this week even as Tesla slumped. The shares jumped...

    Investing

    The Fox Corporation (NASDAQ: FOX) stock price has been under pressure as investors come to terms with the abrupt firing of Tucker Carlson. The...

    Investing

    NatWest (LON: NWG) share price rose sharply, helped by the strong results from Barclays. The stock jumped to a high of 274.8p, which was...




    Disclaimer: Oldamericanbroker.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the-company.


    Copyright © 2025 Oldamericanbroker.com